Galadlas, Baby Boy -.

HRN: 27-66-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/26/2025
09/02/2025
IV
15mg
Q24H
PSNB
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines